Core Laboratories Inc

Core Laboratories Inc

CLB

Get informed when a big investor buys or sells

+ Follow
Market Cap$518.59M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Core Laboratories IncCore Laboratories Inc20.10.36%10%10.1
$21.00

Target Price by Analysts

100.2% upsideCore Laboratories Target Price DetailsTarget Price
$8.70

Current Fair Value

17% downside

Overvalued by 17% based on the discounted cash flow analysis.

Share Statistics

Market cap$518.59 Million
Enterprise Value$535.17 Million
Dividend Yield$0.04 (0.36%)
Earnings per Share$0.68
Beta1.08
Outstanding Shares46,878,000

Return

Return on Equity9.50%ROE
Return on Assets4.51%
Return on Invested Capital9.83%

Valuation & Multiples

P/E Ratio20.09P/E Ratio
PEG-45.66PEG
Price to Sales0.95Price to Sales
Price to Book Ratio2.1Price to Book Ratio
Enterprise Value to Revenue1.03
Enterprise Value to EBIT11.2
Enterprise Value to Net Income20
Total Debt to Enterprise0.07
Debt to Equity0.14Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
July 29, 2026
EPS Estimate
$0.09
Average shareholder expectation
Revenue Estimate
$126.26 M
Average shareholder expectation

Next Earnings Call

Expected Date
October 28, 2026
EPS Estimate
$0.17
Average shareholder expectation
Revenue Estimate
$132.16 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0291▼ 12.15%
Total Calls10,300▼ 56.90%
Total Puts300▼ 91.67%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %113.62%▲ 3.94%
Total Invested$619.44M▼ 26.99%
Investors Holding189▼ 3.00%

ESG Score

No data

About Core Laboratories N.V.

4,700 employees

Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more tha...